Divis Laboratories shares fall 2.01%; among top losers on Nifty Next 50

Shares of Divis Laboratories declined 2.01% to Rs 5,957.50 in Wednesday's trading session, as of 11:46 am. The stock is among the top losers on the Nifty Next 50 index, reflecting a noticeable decrease from its previous close.

Financial Snapshot:

The following tables provide a summary of Divis Laboratories' financial performance:

Consolidated Quarterly Results:

The company's consolidated revenue for the quarter-ending June 2025 was Rs 2,410.00 Crore, compared to Rs 2,118.00 Crore for the quarter-ending June 2024, indicating a year-over-year increase. The net profit for the quarter-ending June 2025 was Rs 545.00 Crore, compared to Rs 430.00 Crore in the corresponding quarter of the previous year. The Earnings Per Share (EPS) stood at 20.49 for the quarter-ending June 2025, up from 16.20 in the quarter-ending June 2024.

Consolidated Yearly Results:

The consolidated annual revenue for 2025 stood at Rs 9,360.00 Crore, a notable increase compared to Rs 7,845.00 Crore in 2024. The net profit for 2025 was Rs 2,191.00 Crore, up from Rs 1,600.00 Crore in 2024. The Earnings Per Share (EPS) increased to 82.53 in 2025 from 60.27 in 2024. The Book Value Per Share (BVPS) also rose from 512.11 in 2024 to 564.87 in 2025. Return on Equity (ROE) increased to 14.63 in 2025 as compared to 11.78 in year 2024. The debt to equity ratio remained at 0.00 from year 2021 to 2025, indicating a debt-free status.
The total income for the year ending March 2025 was Rs 9,712 Crore, while the total expenditure was Rs 6,794 Crore. Earnings Before Interest and Tax (EBIT) stood at Rs 2,918 Crore. After accounting for interest and tax, the net profit was Rs 2,191 Crore.
The cash flow from operating activities for the year ending March 2025 was Rs 1,653 Crore, indicating the company's ability to generate cash from its core business operations. The cash flow from investing activities was Rs -804 Crore, reflecting investments made by the company. The cash flow from financing activities was Rs -799 Crore. The net cash flow stood at Rs 50 Crore.
As of March 2025, the share capital stood at Rs 53 Crore, with reserves and surplus at Rs 14,916 Crore, demonstrating a strong financial foundation. Current liabilities amounted to Rs 1,452 Crore, and other liabilities were Rs 511 Crore, resulting in total liabilities of Rs 16,932 Crore.

Key Financial Ratios (Year Ending March 2025):

Corporate Actions:

Divis Laboratories announced a final dividend of Rs 30 per share (1500%) on May 19, 2025, with an effective date of July 25, 2025. The company had announced a final dividend of Rs 30 per share on May 27, 2024, with an effective date of August 2, 2024.